Page last updated: 2024-11-02

moxonidine and Angor Pectoris

moxonidine has been researched along with Angor Pectoris in 1 studies

moxonidine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Moxonidine is a new centrally active imidazoline-receptor agonist being effectively applied in the treatment of arterial hypertension due to its sympathicolytic potency."7.71[Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and the neurohumoral system in patients with essential hypertension. Effects of moxonidine on coronary circulation]. ( Hamel, M; Hamm, C; Miric, M; Mitrovic, V; Thormann, J, 2001)
"Moxonidine is a new centrally active imidazoline-receptor agonist being effectively applied in the treatment of arterial hypertension due to its sympathicolytic potency."3.71[Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and the neurohumoral system in patients with essential hypertension. Effects of moxonidine on coronary circulation]. ( Hamel, M; Hamm, C; Miric, M; Mitrovic, V; Thormann, J, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitrovic, V1
Hamel, M1
Miric, M1
Thormann, J1
Hamm, C1

Other Studies

1 other study available for moxonidine and Angor Pectoris

ArticleYear
[Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and the neurohumoral system in patients with essential hypertension. Effects of moxonidine on coronary circulation].
    Zeitschrift fur Kardiologie, 2001, Volume: 90, Issue:12

    Topics: Aged; Angina Pectoris; Antihypertensive Agents; Blood Flow Velocity; Coronary Circulation; Electroca

2001